
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aram... Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1409 | -7.26288659794 | 1.94 | 2.09 | 1.7501 | 55566 | 1.90838469 | CS |
4 | -0.8909 | -33.1189591078 | 2.69 | 2.89 | 1.7501 | 30810 | 2.16995809 | CS |
12 | -1.4909 | -45.3161094225 | 3.29 | 3.61 | 1.7501 | 32079 | 2.72229594 | CS |
26 | -1.7409 | -49.1779661017 | 3.54 | 23.8 | 1.7501 | 1374554 | 12.08210789 | CS |
52 | -2.7609 | -60.5460526316 | 4.56 | 23.8 | 1.7501 | 826207 | 10.7344909 | CS |
156 | -248.4009 | -99.2809352518 | 250.2 | 330.858 | 1.7501 | 372639 | 22.98110627 | CS |
260 | -867.6009 | -99.7930641822 | 869.4 | 1126.782 | 1.7501 | 295752 | 174.53451651 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.